Immunovant, Inc.

NasdaqGS:IMVT 株式レポート

時価総額：US$3.9b

Immunovant 所有権

大株主は誰で、インサイダーは売買しているのか？

最近のインサイダー取引

NasdaqGS:IMVT 企業または個人による最近のインサイダー取引
日付価値名称エンティティ役割株式最高価格
20 Nov 24SellUS$106,228Eva BarnettIndividual4,174US$25.45
20 Nov 24SellUS$85,334William MaciasIndividual3,353US$25.45
20 Nov 24SellUS$424,811Peter SalzmannIndividual16,692US$25.45
20 Nov 24SellUS$92,893Mark LevineIndividual3,650US$25.45
23 Oct 24SellUS$80,912Jay StoutIndividual2,740US$29.53
23 Oct 24SellUS$94,171Michael GeffnerIndividual3,189US$29.53
23 Oct 24SellUS$128,780Mark LevineIndividual4,361US$29.53
16 Oct 24SellUS$94,172Eva BarnettIndividual3,271US$28.79
16 Oct 24SellUS$91,783William MaciasIndividual3,188US$28.79
16 Oct 24SellUS$82,339Mark LevineIndividual2,860US$28.79
16 Oct 24SellUS$261,845Peter SalzmannIndividual9,095US$28.79
09 Oct 24SellUS$131,838Peter SalzmannIndividual4,460US$29.56
09 Oct 24SellUS$152,589Eva BarnettIndividual5,162US$29.56
21 Aug 24SellUS$480,052Peter SalzmannIndividual15,068US$32.32
21 Aug 24SellUS$120,045Eva BarnettIndividual3,768US$32.32
21 Aug 24SellUS$96,437Julia ButchkoIndividual3,027US$32.32
21 Aug 24SellUS$96,437William MaciasIndividual3,027US$32.32
21 Aug 24SellUS$104,976Mark LevineIndividual3,295US$32.32
24 Jul 24SellUS$111,456Mark LevineIndividual4,015US$27.76
24 Jul 24SellUS$95,939Michael GeffnerIndividual3,456US$27.76
24 Jul 24SellUS$78,089Jay StoutIndividual2,813US$27.76
17 Jul 24SellUS$257,888Peter SalzmannIndividual8,685US$30.55
17 Jul 24SellUS$85,132Julia ButchkoIndividual2,867US$30.55
17 Jul 24SellUS$92,733Eva BarnettIndividual3,123US$30.55
17 Jul 24SellUS$90,386William MaciasIndividual3,044US$30.55
17 Jul 24SellUS$74,382Mark LevineIndividual2,505US$30.55
09 Jul 24SellUS$129,609Peter SalzmannIndividual4,619US$28.06
09 Jul 24SellUS$42,848Julia ButchkoIndividual1,527US$28.06
09 Jul 24SellUS$133,201Eva BarnettIndividual4,747US$28.06
22 May 24SellUS$96,125Mark LevineIndividual3,242US$29.65
22 May 24SellUS$96,274William MaciasIndividual3,247US$29.65
22 May 24SellUS$96,274Julia ButchkoIndividual3,247US$29.65
22 May 24SellUS$479,233Peter SalzmannIndividual16,163US$29.65
22 May 24SellUS$119,845Eva BarnettIndividual4,042US$29.65
24 Apr 24SellUS$114,531Mark LevineIndividual3,963US$28.90
24 Apr 24SellUS$94,243Michael GeffnerIndividual3,261US$28.90
24 Apr 24SellUS$209,207Jay StoutIndividual7,239US$28.90
17 Apr 24SellUS$990,269Peter SalzmannIndividual34,079US$29.94
17 Apr 24SellUS$293,923Julia ButchkoIndividual10,115US$29.94
17 Apr 24SellUS$285,554Mark LevineIndividual9,827US$29.94
17 Apr 24SellUS$356,049Eva BarnettIndividual12,253US$29.94
17 Apr 24SellUS$240,602William MaciasIndividual8,280US$29.94
09 Apr 24SellUS$149,882Peter SalzmannIndividual4,807US$31.18
09 Apr 24SellUS$115,023Eva BarnettIndividual3,689US$31.18
09 Apr 24SellUS$32,833Julia ButchkoIndividual1,053US$31.18
22 Feb 24SellUS$486,362Peter SalzmannIndividual13,454US$36.15
22 Feb 24SellUS$77,144Mark LevineIndividual2,134US$36.15
22 Feb 24SellUS$77,578Julia ButchkoIndividual2,146US$36.15
22 Feb 24SellUS$80,289William MaciasIndividual2,221US$36.15
22 Feb 24SellUS$105,920Eva BarnettIndividual2,930US$36.15
26 Jan 24SellUS$114,778Mark LevineIndividual3,027US$38.45
26 Jan 24SellUS$383,012Michael GeffnerIndividual10,101US$38.45
18 Jan 24SellUS$17,397William MaciasIndividual424US$41.03
11 Jan 24SellUS$147,023Eva BarnettIndividual3,515US$42.43
05 Jan 24SellUS$147,568Peter SalzmannIndividual3,824US$38.59
05 Jan 24SellUS$50,051Julia ButchkoIndividual1,297US$38.59
01 Dec 23SellUS$490,668Atul PandeIndividual12,350US$40.46

インサイダー取引量

インサイダー購入: IMVT インサイダー は過去 3 か月間に株式を売却しただけです。

所有権の内訳

IMVT の所有者構成は？
オーナータイプ株式数所有比率
個人インサイダー1,308,1050.812%
上場企業79,805,33149.6%
機関79,940,14849.6%

株式の希薄化: 過去1年間に株主の株式が大幅に希薄化されることはありませんでした。

上位株主

25 上位株主96.95 ％を所有。
所有権名称株式現在の価値変化率ポートフォリオ
54.4%
Roivant Sciences Ltd.
79,805,331US$2.1b0%データなし
8.54%
FMR LLC
12,537,561US$336.9m19.6%0.02%
4.54%
The Vanguard Group, Inc.
6,658,800US$178.9m2.29%データなし
3.44%
BlackRock, Inc.
5,053,150US$135.8m2.79%データなし
3.09%
T. Rowe Price Group, Inc.
4,540,063US$122.0m52%0.01%
2.96%
Deep Track Capital, LP
4,347,464US$116.8m50.8%3.61%
2.42%
Armistice Capital LLC
3,548,000US$95.3m4.45%2.4%
2.06%
State Street Global Advisors, Inc.
3,022,342US$81.2m11.2%データなし
1.62%
Perceptive Advisors LLC
2,378,762US$63.9m23.7%1.39%
1.58%
Viking Global Investors LP
2,320,902US$62.4m0%0.21%
1.28%
Alpine Global Management, LLC
1,882,704US$50.6m-1.31%13.45%
1.03%
Geode Capital Management, LLC
1,510,926US$40.6m6.85%データなし
0.96%
Woodline Partners LP
1,414,977US$38.0m-22.4%0.31%
0.93%
Paradigm Biocapital Advisors LP
1,362,827US$36.6m0%1.28%
0.84%
Pictet Asset Management Limited
1,230,309US$33.1m4.72%0.03%
0.83%
Baker Bros. Advisors LP
1,225,410US$32.9m164%0.3%
0.83%
Rock Springs Capital Management LP
1,221,309US$32.8m3.01%1.08%
0.78%
Hood River Capital Management LLC
1,143,567US$30.7m0%0.44%
0.77%
ADAR1 Capital Management, LLC
1,131,707US$30.4m137%5.35%
0.75%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,104,910US$29.7m27.7%0.01%
0.75%
Logos Global Management, L.P.
1,100,000US$29.6m91.3%3.49%
0.69%
Franklin Resources, Inc.
1,017,396US$27.3m-1.55%0.01%
0.67%
Capital Research and Management Company
976,237US$26.2m0%データなし
0.65%
Principal Global Investors, LLC
951,124US$25.6m69.9%0.01%
0.56%
Tavistock Life Sciences
825,000US$22.2m0%1.43%